In conclusion, our findings indicate that after irradiation of HCC cells CD133-expressing liver CSCs have significant metastatic capabilities, the maintenance of which might be inhibited by suppression of ADAM17. This evidence concerns the gene ADAM17 and hepatocellular carcinoma.